company coverage

Bubs Australia Limited research (ASX:BUB)

Coverage of Bubs Australia Limited collects dated research on business quality, return drivers, balance-sheet resilience, valuation scenarios, and what would change the thesis for ASX:BUB.

1 edition linked in this hub.

Coverage

  1. Bubs can stay on US shelves; 13 cents still asks for a profitBubs Australia (ASX:BUB) gained 30% on permanent FDA access. The approval removes a regulatory cliff, while cash conversion remains unsettled.